ScholarIQanswers from OpenAlex
Bayer HealthCare
FunderResearch funding and supported work
Bayer HealthCare is a funder indexed in ScholarIQ from OpenAlex.
What is known about Bayer HealthCare?
ScholarIQrecord summary
German multinational pharmaceutical, chemical, and agricultural biotechnology company
How many works does Bayer HealthCare have?
ScholarIQindexed works
Bayer HealthCare has 5,705 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Bayer HealthCare?
ScholarIQopenalex
The OpenAlex for Bayer HealthCare is on the source record.
What is the ROR of Bayer HealthCare?
ScholarIQror
The ROR for Bayer HealthCare is on the source record.
What are the most-cited papers on Bayer HealthCare?
ScholarIQmost cited works
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
Bertram Pitt, Lars Køber, Piotr Ponikowski, Mihai Gheorghiade, Gerasimos Filippatos, Henry Krum, Christina Nowack, Peter Kolkhof, So Young Kim, Faı̈ez Zannad
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
Helen M. Colhoun, Ildiko Lingvay, Paul Brown, John Deanfield, Kirstine Brown‐Frandsen, Steven E. Kahn, Jorge Plutzky, Koichi Node, Alexander Parkhomenko, Lars Rydén, John Wilding, Johannes F.E. Mann, Katherine R. Tuttle, Thomas Idorn, Naveen Rathor, A. Michael Lincoff
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, Godela Brosnahan, Melissa A. Cadnapaphornchai, Arlene B. Chapman, Émilie Cornec-Le Gall, Joost P.H. Drenth, Ron T. Gansevoort, Peter C. Harris, Tess Harris, Shigeo Horie, Max C. Liebau, Michele Liew, Andrew Mallett, Changlin Mei, Djalila Mekahli, Dwight Odland, Albert Ong, Luiz F. Onuchic, York Pei, Ronald D. Perrone, Gopala K. Rangan, Brian Rayner, Roser Torrá, Ethan M. Balk, Craig E. Gordon, Amy Earley, Reem A. Mustafa, Olivier Devuyst
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease
Rajiv Agarwal, Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos, Jolanta Małyszko, Luís M. Ruilope, Patrick Rossignol, Peter Rossing, Roberto Pecoits‐Filho, Stefan D. Anker, Amer Joseph, Robert Lawatscheck, Daniel J. Wilson, Martin Gebel, George L. Bakris
A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines
Jihong Zong, Adina Rojubally, Xiaoyun Pan, Birgit Wolf, Scott Greenfeder, Alexander J. Upton, Joette Gdovin Bergeson